A phase 3 trial of Intec Pharma’s Parkinson's disease drug has missed its primary endpoint, sparking a steep decline in the company’s stock. The candidate uses a drug delivery system designed to ...

JERUSALEM, March 15, 2021 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") announced today that it has entered into a definitive agreement for a business combination with ...

"We entered 2020 with a focused agenda for leveraging our Accordion Pill platform in both the near- and long-term, with goals to outlicence our late-stage Parkinson's disease program, to advance our ...

U.S. billing firm CSG Systems will buy Intec Telecom Systems, a British-based rival, for 236.7 million pounds ($370.9 million), in a deal supported by private equity firm General Atlantic, which has ...

SANTA MONICA, Calif., Aug. 19, 2025 /PRNewswire/ -- Intec Bioplastics, Inc. is proud to announce their new customer incentive Buy Back Program, which is focused on used stretch wrap film and stretch ...